Establishment Labs Holdings Inc

Aktienanalyse zu Establishment Labs Holdings Inc (ESTA)

$69.550

+0.223 (+0.32%)Zum Schluss

Loading chart…
High
71.060
Open
69.840
VWAP
69.98
Vol
372.23K
Mkt Cap
1.21B
Low
69.320
Amount
26.05M
EV/EBITDA, TTM
-142.51

Establishment Labs Holdings Inc. is Costa Rica-based medical technology and aesthetics company that is focused on women's health reconstruction market. The Company is engaged in the designing, developing, manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. The main activities are conducted at two manufacturing facilities in Costa Rica including Motiva Implants brand sold in over 80 countries globally through a combination of distributors and direct sales to customers.

AI analysis of Establishment Labs Holdings Inc (ESTA)

hold

Establishment Labs Holdings Inc is currently a hold. The stock is priced at $70.64, significantly below analyst price targets of $92 and $105, indicating potential upside. However, the RSI is at a low 23.939, suggesting the stock is oversold, which could lead to further declines in the short term. The company reported a strong Q2 2026 revenue of $67.5 million, a 31.7% year-over-year increase, but remains unprofitable with a net income loss of $11.7 million in Q2 2026. The main risk is the high insider selling activity, which has increased by 141.15% over the last month, indicating potential lack of confidence from insiders.

Analyst Ratings (3)

+19.17% upside
Buy
3 Buy
0 Hold
0 Sell
Current: 69.55
Tief
75.00
Durchschnitt
82.88
Hoch
90.00

Citi

2026-08-13

Kursziel

$92

Buy

Canaccord

2026-08-07

Kursziel

$105

Buy

Mizuho

2026-07-15

Kursziel

$105

Outperform

Citi

2026-07-08

Kursziel

$92

Neutral

BTIG

2026-05-07

Kursziel

$90

Buy

Bewertungskennzahlen

The current forward P/E ratio for Establishment Labs Holdings Inc (ESTA) is 0.00, compared to its 5-year average forward P/E of -28.64.

Forward P/E

Overvalued
5Y Average P/E
-28.64
Current P/E
0.00
Überbewertet
-13.72
Unterbewertet
-43.57

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
-84.88
Current EV/EBITDA
-142.51
Überbewertet
42.30
Unterbewertet
-212.05

Forward P/S

Fair
5Y Average P/S
7.17
Current P/S
6.21
Überbewertet
9.16
Unterbewertet
5.19

Alphio AI Price Scenarios for ESTA

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%ESTA

$56.20

Szenariopreis

B

Base

Base · 50%ESTA

$47.64

Szenariopreis

B

Bear

Bear · 25%ESTA

$46.67

Szenariopreis

Whales holding ESTA

A

Affinity Asset Advisors, LLC

+ HoldingESTA

+23.94%

3M Return

B

Boothbay Fund Management, LLC

+ HoldingESTA

+10.69%

3M Return

R

Rice Hall James & Associates, LLC

+ HoldingESTA

+7.48%

3M Return

A

ADAR1 Capital Management, LLC

+ HoldingESTA

+1.71%

3M Return

S

Summit Partners Public Asset Management, LLC

+ HoldingESTA

-6.15%

3M Return

Event-Zeitleiste

2026-06-29 (ET)

08:30:00

Establishment Labs Appoints Taylor Harris to Board of Directors

2026-05-06 (ET)

08:10:00

Company Expects Minimally Invasive Business to Exceed $35M in 2026

08:10:00

Company Reports Q1 Revenue of $59.9M, Exceeding Expectations

2026-04-30 (ET)

09:00:00

Establishment Labs Secures $300M Loan Facility

2026-04-17 (ET)

16:00:00

Asana Short Interest Soars to 33%

News

ESTA FAQ — answered by Alphio AI

Establishment Labs Holdings Inc. is Costa Rica-based medical technology and aesthetics company that is focused on women's health reconstruction market. The Company is engaged in the designing, developing, manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. The main activities are conducted at two manufacturing facilities in Costa Rica including Motiva Implants brand sold in over 80 countries globally through a combination of distributors and direct sales to customers. It operates in the Healthcare sector (ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUP industry).

Establishment Labs Holdings Inc is currently a hold. The stock is priced at $70.64, significantly below analyst price targets of $92 and $105, indicating potential upside. However, the RSI is at a low 23.939, suggesting the stock is oversold, which could lead to further declines in the short term. The company reported a strong Q2 2026 revenue of $67.5 million, a 31.7% year-over-year increase, but remains unprofitable with a net income loss of $11.7 million in Q2 2026. The main risk is the high insider selling activity, which has increased by 141.15% over the last month, indicating potential lack of confidence from insiders.

3 analysts cover ESTA: 3 rate it Buy, 0 Hold and 0 Sell. The average price target is 82.88.

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Kostenlos starten